Launes Gunvor, Hagen Kristen, Öst Lars-Göran, Solem Stian, Hansen Bjarne, Kvale Gerd
Sørlandet Sykehus, Kristiansand, Norway.
Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Front Psychol. 2020 May 27;11:982. doi: 10.3389/fpsyg.2020.00982. eCollection 2020.
The Bergen 4-day treatment (B4DT) for obsessive-compulsive disorder (OCD) was recently tested in a randomized controlled trial, where the results showed that the B4DT was more effective than a self-help intervention (SH) and a waiting list condition (WL). Patients in the SH and WL condition still in need of treatment after the first intervention ( = 26; 13 from each condition) were offered the B4DT. None of the patients declined participation, and there were no dropouts. At post-treatment 59.5% were in remission, 31.0% had treatment response, and 9.5% showed no change. At 3-month follow-up 71.4% were in remission, 19.0% had treatment response, and 9.5% showed no change. There were also significant improvement in self-reported symptoms of OCD, generalized anxiety symptoms, and depressive symptoms. The results are in line with what we previously have found for the B4DT in a number of effectiveness studies. In addition, the results indicate that the patients who previously had received an unsuccessful SH intervention and patients who had first been in a WL condition, profited as much as patients who had received the B4DT as the initial intervention. Implications for clinical guidelines and for dissemination of the B4DT are discussed.
卑尔根强迫症4日疗法（B4DT）最近在一项随机对照试验中进行了测试，结果显示B4DT比自助干预（SH）和等待名单状态（WL）更有效。首次干预后仍需要治疗的SH组和WL组患者（n = 26；每组13人）接受了B4DT。没有患者拒绝参与，也没有患者退出。治疗后，59.5%的患者缓解，31.0%的患者有治疗反应，9.5%的患者无变化。在3个月的随访中，71.4%的患者缓解，19.0%的患者有治疗反应，9.5%的患者无变化。强迫症、广泛性焦虑症状和抑郁症状的自我报告症状也有显著改善。这些结果与我们之前在多项有效性研究中对B4DT的发现一致。此外，结果表明，之前接受不成功的SH干预的患者和最初处于WL状态的患者，与最初接受B4DT干预的患者获益相同。本文讨论了对临床指南和B4DT传播的影响。
